Conjugate Vaccine

Conjugate vaccines represent a sophisticated approach to immunization, particularly effective against bacterial infections that are difficult to address with traditional vaccines. These vaccines work by linking a polysaccharide antigen from a bacterial capsule to a protein carrier, which enhances the immune system's ability to recognize and respond to the pathogen. This conjugation not only improves the vaccine's efficacy but also extends its protective effects to infants and young children, whose immune systems may not respond adequately to polysaccharide antigens alone.

 

    Related Conference of Conjugate Vaccine

    October 31-01, 2024

    36th International Conference on Vaccines and Immunization

    Amsterdam, Netherlands
    November 28-29, 2024

    6th World Congress on Vaccine and Immunology

    Paris, France
    December 05-06, 2024

    36th Annual Congress on Vaccine and Clinical Trials

    Vancouver, Canada
    February 27-28, 2025

    8th International Conference on Vaccines and Immunology

    Paris, France
    April 28-29, 2025

    2nd Global Summit on Vaccines & Emerging Diseases

    Bali, Indonesia

    Conjugate Vaccine Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in